WO2005092095A1 - Bactericidal liquid skin composition - Google Patents

Bactericidal liquid skin composition Download PDF

Info

Publication number
WO2005092095A1
WO2005092095A1 PCT/IB2005/000738 IB2005000738W WO2005092095A1 WO 2005092095 A1 WO2005092095 A1 WO 2005092095A1 IB 2005000738 W IB2005000738 W IB 2005000738W WO 2005092095 A1 WO2005092095 A1 WO 2005092095A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
skin
triclosan
surfactant
alcohol
Prior art date
Application number
PCT/IB2005/000738
Other languages
French (fr)
Inventor
Jacques Schram
Andre Schram
Charles Joubert Marais
Original Assignee
Green World Chemicals Cc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green World Chemicals Cc filed Critical Green World Chemicals Cc
Publication of WO2005092095A1 publication Critical patent/WO2005092095A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08Oxygen or sulfur directly attached to an aromatic ring system
    • A01N31/16Oxygen or sulfur directly attached to an aromatic ring system with two or more oxygen or sulfur atoms directly attached to the same aromatic ring system

Definitions

  • the invention relates to a bactericidal liquid composition with a sustainable effect for cleaning and disinfecting skin, and in particular hands and arms.
  • a liquid skin composition having a sustained bactericidal effect comprising water as a carrier, a lower alcohol, a surfactant and Triclosan.
  • the invention further provides for the surfactant to be selected from the group comprising Sodium Lauryl Ether Sulphate and Coconut Diethanolamide or a combination thereof.
  • the lower alcohol to be selected from the group comprising C2 to C3 alcohols; and for the alcohol to be selected from the group comprising Propyl Alcohol, iso Propyl Alcohol and Ethanol or combinations thereof.
  • composition to comprise the following in mass %: Propyl Alcohol 14 % to 70 %; Triclosan 0.2 % to 2 %; and Surfactant 3 % to 30 %.
  • composition to comprise the following in mass %: Propyl Alcohol about 17 %; Triclosan about 0.3 %; Sodium Lauryl Ether Sulphate about 7 %; and Coconut Diethanolamide about 5 %.
  • composition to include an aromatic compound.
  • the invention provides a liquid bactericidal composition which includes a lower alcohol, Triclosan and a surfactant.
  • the lower alcohol may be any suitable C2 or C3 alcohol.
  • Propyl Alcohol is suitably effective.
  • the alcohol may be selected from Propyl Alcohol, iso Propyl Alcohol and Ethanol or combinations thereof.
  • the surfactant in this embodiment is a combination of Sodium Lauryl Ether Sulphate (SLES) and Coconut Diethanolamide (CDE).
  • the mentioned ingredients may be present in the following mass % ranges:
  • At least the major part of the balance of the composition is made up of purified water as the carrier.
  • this embodiment of the composition comprises the following ingredients in mass %: Propyl Alcohol about 17 %
  • Triclosan about 0.3 %
  • Aromatic compound about 0.2 %
  • the Triclosan is in the form of that marketed by Ciba as IRGASAN ® DP 300.
  • the aromatic compound may be in any suitable form.
  • the ingredients of the composition serve the following purposes:
  • the Propyl Alcohol provides the substantially immediate kill of bacteria.
  • the Triclosan provides the long-lasting antibacterial effect.
  • the at least one surfactant lowers the surface tension between the composition constituents which also has the effect of cleaning the skin and furthermore facilitates sustainability of bactericidal effect of the product.
  • the specific surfactants mentioned Sodium Lauryl Ether Sulphate and Coconut Diethanolamide, are respectively anionic and non-ionic surfactants. These compounds also to a degree serve the purpose of a carrier for the Triclosan.
  • composition kills bacteria, germs, and other disease transmitting organisms to a desirable degree within 1 minute. This is approximately the time required for the hands to dry, and then any other such organisms that come into contact with the covered and protected area of the skin are inhibited against growth.
  • the drying time obviously depends on the amount of composition use and its alcohol concentration.
  • the Triclosan remains on the skin and protects it and inhibits bacterial growth.
  • a rinse of the skin, subsequent to drying of the composition, will remove the surfactant to some degree, but the Triclosan will remain to give the extended bactericidal effect.
  • composition is applied to the skin and allowed to dry without requiring water to rinse makes it very useful in many fields and specifically in rural areas where there is a shortage of cleaning facilities and products.
  • the composition because of its formulation, is also skin-friendly which is highly desirable.
  • the surfactant also moisturises the skin providing a softening effect and protects the skin against the Propyl Alcohol which can otherwise cause irritation or dry the skin out.
  • the invention thus provides a composition for the protection of external skin, in particular on the hands, to first eliminate and then inhibit bacterial growth on treated skin and in so doing contain the transmission of disease through human contact.
  • the composition kills bacteria substantially immediately and inhibits the growth of bacteria for up to 5 or 6 hours after application. It is applied to and allowed to dry on the skin without rinsing.
  • the inhibition is present even after extensive washings after application and represents satisfactory long-lasting antimicrobial and bactericidal efficacy. It will be appreciated that this sustainability on the skin facilitates the prevention of the transmission of diseases from one person to another.
  • Staphylococcus aureus as the pathogenic gram-positive bacteria and Escherichia coli as the gram-negative bacteria.
  • the bactericidal efficacy of the composition was tested under suspension test conditions according to the European Standard EN 12054.
  • Test bacteria Staphylococcus aureus ATCC 9144 Escherichia coli NCTC 8196
  • Nutrient medium Casein soy meal peptone agar Incubation: 24 hours at 37°C
  • Filter paper discs (2 cm diameter) soaked with ethanol were placed in sterile plates. The fingertips were applied on the filter paper discs for 30 sec. in order to allow a migration of the antimicrobial due to the excellent adsorption of ethanol. After 1 minute contact time, the filter discs were dried in the plates and then placed in the middle of agar plates containing the test germs (placebo sample).
  • zones of inhibition around the filter discs are measured and given in mm.
  • Test organisms Staphylococcus aureus ATCC 6538 Enterococcus hirae ATCC 10541 Escherichia coli NCTC 10538 Pseudomonas aeruginosa ATCC 15442
  • Test neutralization mixture TNM 10°.
  • Dilutions of the Test neutralization mixture(TNM) were prepared by pipetting 500 ⁇ l of TNM to 9 ml of TSB + inactivation combination (dilutionlO "2 ) or 50 ⁇ l of TNM to 9 ml TSB + inactivation (dilutionlO -3 ).
  • TNM and each of the dilutions were transferred to a membrane filter device fitted with a membrane filter and filtered immediately. 3. Subsequently the filters were washed with 150 ml of distilled water. The membranes were transferred to TSA and incubated for 48 h at 37°C. 4. After incubation the colonies were counted and reported as log reduction in a table.
  • the bacterial suspension was between 1.5- 5x10 8 cfu/ml.
  • the diluted bacterial suspension was between 6x10 2 -3x10 3 cfu/ml.
  • composition of the current invention shows satisfactory long-lasting antibacterial efficacy against gram-positive and gram-negative bacteria. The hands are thus protected from growth of bacteria even after subsequent rinsing.
  • composition shows strong bactericidal efficacy and fulfills the European requirements (EN12054) for products used for both surgical and hygienic hand rubs.
  • This bactericidal efficacy protects treated skin from bacterial growth for hours after the composition has been applied. It will be appreciated by a person skilled in the art that the composition may be varied from the embodiment set out above without departing from the scope of the current invention. Alternative suitable surfactants will be apparent to a suitably skilled person.

Abstract

The invention is a liquid skin composition having a sustained bactericidal effect which includes a lower alcohol, Triclosan, a surfactant and water as a carrier. The composition is applied and allowed to dry. No rinsing is required. The lower alcohol will be selected from C2 to C3 alcohols and preferably one or a combination of Propyl Alcohol, iso Propyl Alcohol and Ethanol. In a preferred embodiment, the surfactant is a combination of Sodium Lauryl Ether Sulphate and Coconut Diethanolamide. There is also provided for an aromatic compound to be included in the composition. A skin­friendly liquid composition for protection of external skin, in particular on the hands, which first eliminates and then inhibits bacterial growth to contain the transmission of disease through human contact is thus provided.

Description

BACTERICIDAL LIQUID SKIN COMPOSITION
FIELD OF THE INVENTION
The invention relates to a bactericidal liquid composition with a sustainable effect for cleaning and disinfecting skin, and in particular hands and arms.
BACKGROUND OF THE INVENTION
A number of disinfectants, antibacterial soaps, surgical or hygienic hand rubs, and other similar products have an immediate effect of killing germs on application. However, soon after they are applied the effect stops. No sustained protection is offered against subsequent contact with germs. It is well known that human contact is a predominant vehicle for the migration of germs, microbes, bacteria and viruses which result in the transmission of diseases.
In fact, most diseases can be transmitted through human contact and in particular through hand contact. Doctors and healthcare workers are exposed to sick people daily and unwillingly become a vehicle for the transmission of diseases. There are many other examples of how diseases are transmitted through human contact during daily activities. The problem is more prolific in rural areas where cleaning facilities and products are less readily available for people to wash their hands.
OBJECT OF THE INVENTION
It is an object of the current invention to provide a bactericidal liquid composition that will at least assist in the prevention of disease transmission through human contact.
SUMMARY OF THE INVENTION
In accordance with this invention there is provided a liquid skin composition having a sustained bactericidal effect comprising water as a carrier, a lower alcohol, a surfactant and Triclosan.
The invention further provides for the surfactant to be selected from the group comprising Sodium Lauryl Ether Sulphate and Coconut Diethanolamide or a combination thereof.
Further features of the invention provide for the lower alcohol to be selected from the group comprising C2 to C3 alcohols; and for the alcohol to be selected from the group comprising Propyl Alcohol, iso Propyl Alcohol and Ethanol or combinations thereof.
Still further features of the invention provide for the composition to comprise the following in mass %: Propyl Alcohol 14 % to 70 %; Triclosan 0.2 % to 2 %; and Surfactant 3 % to 30 %.
Yet further features of the invention provide for the composition to comprise the following in mass %: Propyl Alcohol about 17 %; Triclosan about 0.3 %; Sodium Lauryl Ether Sulphate about 7 %; and Coconut Diethanolamide about 5 %.
Another feature of the invention provides for the composition to include an aromatic compound.
These and other features of the invention will now become apparent from the following description of the invention by way of example.
DETAILED DESCRIPTION OF THE INVENTION
The invention provides a liquid bactericidal composition which includes a lower alcohol, Triclosan and a surfactant. The lower alcohol may be any suitable C2 or C3 alcohol. In particular, it has been found that Propyl Alcohol is suitably effective. However, the alcohol may be selected from Propyl Alcohol, iso Propyl Alcohol and Ethanol or combinations thereof. The surfactant in this embodiment is a combination of Sodium Lauryl Ether Sulphate (SLES) and Coconut Diethanolamide (CDE).
The mentioned ingredients may be present in the following mass % ranges:
Propyl Alcohol 14 % to 70 % Triclosan 0.2 % to 2 %
Surfactant 3 % to 30 %
At least the major part of the balance of the composition is made up of purified water as the carrier.
More specifically, this embodiment of the composition comprises the following ingredients in mass %: Propyl Alcohol about 17 %
Triclosan about 0.3 %
Sodium Lauryl Ether Sulphate about 7 % Coconut Diethanolamide about 5 %
Aromatic compound about 0.2 %
Water about 70.5 %
The Triclosan is in the form of that marketed by Ciba as IRGASAN®DP 300. The aromatic compound may be in any suitable form.
The ingredients of the composition serve the following purposes:
1. The Propyl Alcohol provides the substantially immediate kill of bacteria. 2. The Triclosan provides the long-lasting antibacterial effect. 3. The at least one surfactant lowers the surface tension between the composition constituents which also has the effect of cleaning the skin and furthermore facilitates sustainability of bactericidal effect of the product.
The specific surfactants mentioned, Sodium Lauryl Ether Sulphate and Coconut Diethanolamide, are respectively anionic and non-ionic surfactants. These compounds also to a degree serve the purpose of a carrier for the Triclosan.
On application the composition kills bacteria, germs, and other disease transmitting organisms to a desirable degree within 1 minute. This is approximately the time required for the hands to dry, and then any other such organisms that come into contact with the covered and protected area of the skin are inhibited against growth. The drying time obviously depends on the amount of composition use and its alcohol concentration.
After the composition has dried, with the water and alcohol evaporated, the surfactant remains on the skin and serves to keep the Triclosan in contact therewith. The result is that, contrary to other surgical rubs, hand rubs, hand soaps, and other similar products which wash off when rinsing ones hands after having killed the bacteria thereon, the Triclosan remains on the skin and protects it and inhibits bacterial growth.
A rinse of the skin, subsequent to drying of the composition, will remove the surfactant to some degree, but the Triclosan will remain to give the extended bactericidal effect.
The fact that the composition is applied to the skin and allowed to dry without requiring water to rinse makes it very useful in many fields and specifically in rural areas where there is a shortage of cleaning facilities and products. The composition, because of its formulation, is also skin-friendly which is highly desirable. The surfactant also moisturises the skin providing a softening effect and protects the skin against the Propyl Alcohol which can otherwise cause irritation or dry the skin out.
The invention thus provides a composition for the protection of external skin, in particular on the hands, to first eliminate and then inhibit bacterial growth on treated skin and in so doing contain the transmission of disease through human contact.
The composition kills bacteria substantially immediately and inhibits the growth of bacteria for up to 5 or 6 hours after application. It is applied to and allowed to dry on the skin without rinsing.
The inhibition is present even after extensive washings after application and represents satisfactory long-lasting antimicrobial and bactericidal efficacy. It will be appreciated that this sustainability on the skin facilitates the prevention of the transmission of diseases from one person to another.
It will be appreciated that different surfactants will facilitate the mentioned sustainability to the composition to a different degree, and will also vary in effectiveness as a carrier. The bactericidal efficacy of the composition on hands has been tested as follows:
The antibacterial effects of the liquid composition with Triclosan in the form of IIRRGGAASSAANN®®DDPP 330000 wweerree ddeetteerrmmiinneedd.. TThhiiss wwaass ddoonnee uunnddeerr in-v/vo finger print test conditions against gram-positive and gram-negative bacteria.
The following germs were selected for the tests: Staphylococcus aureus as the pathogenic gram-positive bacteria and Escherichia coli as the gram-negative bacteria.
The bactericidal efficacy of the composition was tested under suspension test conditions according to the European Standard EN 12054.
Finger print test: (This was conducted in terms of the Ciba Specialty Chemicals Method No. 177e)
In vivo test for determination of the bacteriostatic activity of a product that contains an antimicrobial agent.
Test bacteria: Staphylococcus aureus ATCC 9144 Escherichia coli NCTC 8196
Nutrient medium: Casein soy meal peptone agar Incubation: 24 hours at 37°C
Principle:
1. The hands were wetted for 15 sec. under running tap water.
2. Hands were washed with placebo soap, rinsed with tap water and dried.
3. Filter paper discs (2 cm diameter) soaked with ethanol were placed in sterile plates. The fingertips were applied on the filter paper discs for 30 sec. in order to allow a migration of the antimicrobial due to the excellent adsorption of ethanol. After 1 minute contact time, the filter discs were dried in the plates and then placed in the middle of agar plates containing the test germs (placebo sample).
4. 3ml of the composition was rubbed on the hands. 5 minutes after application the composition was rinsed for 30 seconds and the anti-bacterial efficacy was measured.
5. Ethanol soaked filter paper disks (2 cm diameter) were placed in sterile plates and the same procedure as described under 3. was performed.
6. The procedure described in 5. was repeated 2 and 4 hours after application of the test product in order to determine the long lasting activity of antimicrobial on the skin.
7. The plates were incubated under optimal conditions according to the germ's requirements on temperature and media (see above).
8. Due to the diffusion of the antimicrobial ingredient from the filter into the surrounding agar medium the growth of the test germs is inhibited in the diffusion zone.
For the assessment of the bacteriostatic activity, zones of inhibition around the filter discs are measured and given in mm.
Results:
Figure imgf000008_0001
Figure imgf000009_0001
Each test was performed twice and both results are given in the table. Zl = Zone of Inhibition in mm Vr = Vinson rating 0 = strong growth (no activity) 4 = no growth (very good activity)
Determination of the microbiocidal activity according to the suspension test method EN 12054 (membrane filtration method):
Sample: Composition with IRGASAN®DP 300
Test organisms: Staphylococcus aureus ATCC 6538 Enterococcus hirae ATCC 10541 Escherichia coli NCTC 10538 Pseudomonas aeruginosa ATCC 15442
Test concentration 90% Contact time: 1 and 5 minutes Requirements: At least 3 log reduction after 1 minute contact time in case of hygienic hand wash and after 3-5 minutes contact time in case of surgical hand wash. Inactivating medium for dilution: NaCI-Peptone + 3% Tween 80 + 0.3% lecithin + 0.1 % histidine + 0.5% Na-Thiosulfate(TLHNa) Nutrient medium: Tryptic-soya-agar, (TSA) Incubation of plates: 24-48 hours at 37°C Preparation of the inoculums: Before using the bacteria culture for the suspension test, three consecutive daily transfers were made on Tryptic soy agar slants and incubated at 37°C, then washed with tryptone-water and diluted up to a content of 1.5 - 5.0 x 108 cfu/ml.
Principle of the method:
1. 1 ml of a bacterial suspension was added to 9 ml of formulation and mixed thoroughly. After the prescribed exposure time of 5 minutes at 21 °C +/- 1 °C aliquots of 0.1 ml of the test mixture were taken and added to 50 ml of TLHNa combination (= Test neutralization mixture, TNM 10°.) Dilutions of the Test neutralization mixture(TNM) were prepared by pipetting 500 μl of TNM to 9 ml of TSB + inactivation combination (dilutionlO"2 ) or 50 μl of TNM to 9 ml TSB + inactivation (dilutionlO-3 ).
2. The TNM and each of the dilutions were transferred to a membrane filter device fitted with a membrane filter and filtered immediately. 3. Subsequently the filters were washed with 150 ml of distilled water. The membranes were transferred to TSA and incubated for 48 h at 37°C. 4. After incubation the colonies were counted and reported as log reduction in a table.
Verification of methodology:
For each bacterial suspension it was checked that -
1. The bacterial suspension was between 1.5- 5x108cfu/ml.
2. The diluted bacterial suspension was between 6x102-3x103 cfu/ml.
3. The validation of inactivation of filtration process was in the normal range.
Results:
Bactericidal activity according to EN 12054 in log bacteria reduction / contact time 1 and 5 minutes
Figure imgf000011_0001
Conclusion based on the tests:
The composition of the current invention shows satisfactory long-lasting antibacterial efficacy against gram-positive and gram-negative bacteria. The hands are thus protected from growth of bacteria even after subsequent rinsing.
In addition the composition shows strong bactericidal efficacy and fulfills the European requirements (EN12054) for products used for both surgical and hygienic hand rubs. This bactericidal efficacy protects treated skin from bacterial growth for hours after the composition has been applied. It will be appreciated by a person skilled in the art that the composition may be varied from the embodiment set out above without departing from the scope of the current invention. Alternative suitable surfactants will be apparent to a suitably skilled person.

Claims

1. A liquid skin composition having a sustained bactericidal effect comprising water as a carrier, a lower alcohol, a surfactant and Triclosan.
2. A composition as claimed in claim 1 in which the surfactant is selected from the group comprising Sodium Lauryl Ether Sulphate and Coconut Diethanolamide or a combination thereof.
3. A composition as claimed in claim 1 or claim 2 in which the lower alcohol is selected from the group comprising C2 to C3 alcohols.
4. A composition as claimed in claim 3 in which the alcohol is selected from the group comprising Propyl Alcohol, iso Propyl Alcohol and Ethanol or combinations thereof.
A composition as claimed in claim 4 which comprises the following in mass %: Propyl Alcohol 14 % to 70 %; Triclosan 0.2 % to 2 %; and Surfactant 3 % to 30 %.
6. A composition as claimed in claim 5 which comprises the following in mass %: Propyl Alcohol about 17 %; Triclosan about 0.3 %; Sodium Lauryl Ether Sulphate about 7 %; and Coconut Diethanolamide about 5 %.
7. A composition as claimed in any of the preceding claims which includes an aromatic compound.
8. A composition as claimed in any of the preceding claims in which the Triclosan is IRGASAN®DP 300.
PCT/IB2005/000738 2004-03-23 2005-03-22 Bactericidal liquid skin composition WO2005092095A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA2003/7397 2004-03-23
ZA200307397 2004-03-23

Publications (1)

Publication Number Publication Date
WO2005092095A1 true WO2005092095A1 (en) 2005-10-06

Family

ID=34962064

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/000738 WO2005092095A1 (en) 2004-03-23 2005-03-22 Bactericidal liquid skin composition

Country Status (1)

Country Link
WO (1) WO2005092095A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3723990A1 (en) * 1986-07-23 1988-02-04 Ciba Geigy Ag Microbicidal preparation
US6531434B1 (en) * 1997-05-20 2003-03-11 Novapharm Research (Australia) Pty. Alkylpolyglucosides containing disinfectant compositions active against pseudomonas microorganism

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3723990A1 (en) * 1986-07-23 1988-02-04 Ciba Geigy Ag Microbicidal preparation
US6531434B1 (en) * 1997-05-20 2003-03-11 Novapharm Research (Australia) Pty. Alkylpolyglucosides containing disinfectant compositions active against pseudomonas microorganism

Similar Documents

Publication Publication Date Title
US6846498B2 (en) Antimicrobial composition formulated with essential oils
DE69923695T2 (en) TOPICAL-DERMAL ANTIMICROBIAL COMPOSITIONS
US5591442A (en) Skin antiseptic and hand disinfectant
US5767163A (en) Lubricating and/or germicidal composition
US6352702B1 (en) Antimicrobial composition
US20120141570A1 (en) Paper product with disinfecting properties
JP2009519220A (en) Pathogen-control drug
JP6129843B2 (en) Disinfecting compositions and their use
WO2006097758A2 (en) Antimicrobial composition
WO1997029742A1 (en) Lubricating and/or germicidal composition
FR2667220A1 (en) COMPOSITION OF CLEANING-DECONTAMINATING AGENT, PARTICULARLY FOR SURGICAL INSTRUMENTS.
US6015836A (en) Chemical disinfectant employing dual chain quaternary ammonium compounds with iodine
JPH072615A (en) Cloth impregnated with antimicrobial disinfectant
WO2005092095A1 (en) Bactericidal liquid skin composition
EP1512409B1 (en) Composition against infestment of lice
JPH07252105A (en) Liquid disinfectant
EP3945821B1 (en) Disinfectant compositions
EP3949733A1 (en) Disinfectant compositions
US8859478B2 (en) Cleaning composition/solutions and use thereof
KR20110060981A (en) Anti-bacterial skin germicide cleaner composition
EP3918916A1 (en) Compositions
RU2317110C1 (en) Cutaneous antiseptic agent "septusin-antisept"
Shintre et al. Evaluation of an alcohol-based surgical hand disinfectant containing a synergistic combination of farnesol and benzethonium chloride for immediate and persistent activity against resident hand flora of volunteers and with a novel in vitro pig skin model
RU2413496C2 (en) Alcohol-free scrub-up composition and method of using thereof
EA013233B1 (en) Antiseptic composition for desinfection of cutaneous covering, method for preparing thereof ana semi-product therefor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase